Akeso (HKSE:09926) Other Operating Expense : HK$-58 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Akeso Other Operating Expense?

Akeso's Other Operating Expense for the six months ended in Dec. 2024 was HK$-21 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-58 Mil.

Akeso's quarterly Other Operating Expense declined from Dec. 2023 (HK$-28 Mil) to Jun. 2024 (HK$-37 Mil) but then increased from Jun. 2024 (HK$-37 Mil) to Dec. 2024 (HK$-21 Mil).

Akeso's annual Other Operating Expense declined from Dec. 2022 (HK$-122 Mil) to Dec. 2023 (HK$-129 Mil) but then increased from Dec. 2023 (HK$-129 Mil) to Dec. 2024 (HK$-58 Mil).

Akeso Other Operating Expense Historical Data

The historical data trend for Akeso's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Other Operating Expense Chart

Akeso Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

-82.03

-103.86

-121.95

-129.42

-57.96

Akeso Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Operating Expense	Get a 7-Day Free Trial								-48.92	-101.24	-28.18	-37.21	-21.06

Akeso Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-58 Mil.

Akeso Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Akeso's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (HKSE:09926) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

AKESF:USA 4RY:Germany

Address

No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437

Website

https://www.akesobio.com

Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China, and also has its presence in USA and Other regions.

Executives

Xia Yu	2501 Other
Li Baiyong	2501 Other
Wang Zhongmin Maxwell	2501 Other
Green Court Capital Holdings Limited	2201 Interest of corporation controlled by you
Green Court Capital Management Limited	2102 Investment manager
Green Court Management Holdings Llc	2201 Interest of corporation controlled by you
Yao Yulin	2201 Interest of corporation controlled by you
Shenzhen Capital Group Co., Ltd.	2201 Interest of corporation controlled by you
Xia Yu	2501 Other
Shen Zhen Shi Chuang Xin Tou Zi Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Zheng Xun
Zhong Shan Shi Xun Xiang Gu Quan Tou Zi Guan Li Qi Ye You Xian He Huo
Cantrust (far East) Limited	2301 Trustee
Aquae Hyperion Limited	2101 Beneficial owner
Htkf Investments Limited	2101 Beneficial owner

Akeso Headlines

No Headlines